Yifeng Pharmacy (603939) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Based on the latest financial reports, Yifeng Pharmacy (603939) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥641.93 Million ≈ $93.93 Million USD) by net assets (CN¥11.66 Billion ≈ $1.71 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Yifeng Pharmacy for the company's overall valuation and market capitalisation.

Yifeng Pharmacy - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Yifeng Pharmacy's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Yifeng Pharmacy Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yifeng Pharmacy ranked by their cash flow conversion efficiency. Explore Yifeng Pharmacy cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Oscar Health Inc NYSE:OSCR	0.685x
Pangang Group Vanadium Titanium & Resources Co Ltd SHE:000629	0.031x
Veradermics, Incorporated NYSE:MANE	-0.054x
Allete Inc NYSE:ALE	0.031x
Liaoning Port Co Ltd SHG:601880	0.032x
Aris Mining Corporation NYSE MKT:ARMN	0.070x
Boot Barn Holdings Inc NYSE:BOOT	0.163x
AGL Energy Ltd AU:AGL	0.115x

Annual Cash Flow Conversion Efficiency for Yifeng Pharmacy (2011–2024)

The table below shows the annual cash flow conversion efficiency of Yifeng Pharmacy from 2011 to 2024. View current stock price of Yifeng Pharmacy for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥11.39 Billion ≈ $1.67 Billion	CN¥4.22 Billion ≈ $617.70 Million	0.370x	-17.00%
2023-12-31	CN¥10.45 Billion ≈ $1.53 Billion	CN¥4.66 Billion ≈ $682.38 Million	0.446x	+3.86%
2022-12-31	CN¥9.12 Billion ≈ $1.33 Billion	CN¥3.92 Billion ≈ $573.66 Million	0.430x	+57.21%
2021-12-31	CN¥7.86 Billion ≈ $1.15 Billion	CN¥2.15 Billion ≈ $314.61 Million	0.273x	+18.34%
2020-12-31	CN¥5.78 Billion ≈ $846.10 Million	CN¥1.34 Billion ≈ $195.45 Million	0.231x	+12.93%
2019-12-31	CN¥4.71 Billion ≈ $689.07 Million	CN¥963.23 Million ≈ $140.95 Million	0.205x	+67.01%
2018-12-31	CN¥4.17 Billion ≈ $610.18 Million	CN¥510.71 Million ≈ $74.73 Million	0.122x	+22.77%
2017-12-31	CN¥3.18 Billion ≈ $465.28 Million	CN¥317.20 Million ≈ $46.42 Million	0.100x	+112.11%
2016-12-31	CN¥2.98 Billion ≈ $435.39 Million	CN¥139.94 Million ≈ $20.48 Million	0.047x	-63.22%
2015-12-31	CN¥1.42 Billion ≈ $207.70 Million	CN¥181.52 Million ≈ $26.56 Million	0.128x	-64.12%
2014-12-31	CN¥595.76 Million ≈ $87.18 Million	CN¥212.35 Million ≈ $31.07 Million	0.356x	+14.22%
2013-12-31	CN¥502.20 Million ≈ $73.49 Million	CN¥156.71 Million ≈ $22.93 Million	0.312x	+64.60%
2012-12-31	CN¥425.82 Million ≈ $62.31 Million	CN¥80.73 Million ≈ $11.81 Million	0.190x	-45.08%
2011-12-31	CN¥356.28 Million ≈ $52.14 Million	CN¥122.99 Million ≈ $18.00 Million	0.345x	--

About Yifeng Pharmacy

SHG:603939 China Pharmaceutical Retailers

Market Cap

$3.94 Billion

CN¥26.92 Billion CNY

Market Cap Rank

#4184 Global

#643 in China

Share Price

CN¥22.20

Change (1 day)

+0.23%

52-Week Range

CN¥17.98 - CN¥25.49

All Time High

CN¥967.78